A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-Yte, Has an Extended Half-Life in Healthy Adults

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01285-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search